Paediatric pulmonary arterial hypertension (PAH) shares common features of adult disease,
but is associated with several additional disorders and challenges that require unique …

Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

Pulmonary hypertension (PH) in neonates, infants, children, adolescents, and young adults
is a complex condition that can be associated with several cardiac, pulmonary, and systemic …

Abstract Purpose of Review This review focuses on the therapeutic management and
individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food …

Background Despite the use and purported benefits of balloon atrial septostomy (BAS), its
safety, efficacy, and therapeutic role in the setting of advanced pulmonary arterial …

Treatment of children and adults with pulmonary hypertension (PH) with or without cardiac
dysfunction has improved in the last two decades. The so-called pulmonary arterial …

Paediatric pulmonary arterial hypertension (PAH) shares common features with adult
disease, but is associated with several additional disorders and challenges that require …

Objectives Despite advances in treatment of idiopathic pulmonary arterial hypertension
(IPAH), there remains no medical cure, and patients can experience disease progression …

Pediatric pulmonary hypertension is a complex disease with multiple, diverse etiologies
affecting the premature neonate to the young adult. Pediatric pulmonary arterial …

Pediatric pulmonary hypertension (PPH) is a multifactorial disease with diverse etiologies
and presenting features. Pulmonary hypertension (PH), defined as elevated pulmonary …